Partnership Improves Equitable Access to "Count the Kicks" Stillbirth Prevention Program

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceutical industry, announced the release of version 10.5 of its award-winning Trial Interactive eClinical platform. This new version is a significant update and brings new benefits to sponsors, enabling them to further automate oversight for proactive and predictive trial management.

Trial Interactive, a leading eClinical platform supporting global clinical trials and product development for the biopharmaceutical industry, was selected as the winner in the “Best Content Management Innovation” category for the Saas Awards.

Blue Cross Blue Shield Saves $1.2 Million Leveraging Translation Automation to Meet CMS Deadlines for Open Enrollment

eClinical technologies contribute to a more cost-effective, holistic, and accurate representation of patient data. Overcome five challenges of implementation.

A centralized platform for global content development can empower patient engagement teams to deliver personalized care to a broad scope of patient populations.

A unitary patent is intended to simplify the European patent system in up to 25 EU Member States. Learn how unitary patents will affect life sciences companies.

The Quality Review of Documents (QRD V9) update came into effect on January 28, 2022. The new version consists of a set of guidelines established by the European Medicines Agency (EMA) outlining the responsibilities and duties of those who ensure the quality of veterinary medicines. The update to V9.0 includes several key changes aimed at improving the overall quality of veterinary care and prioritizing animal welfare.

Life sciences organizations face challenges with recruiting for clinical trials using social media due to regulations. Learn four ways to overcome challenges.

International Women's Day is celebrated annually on March 8 to recognize the social, economic, cultural, and political achievements of women worldwide.

Now that the EU Clinical Trial Regulation is in effect, what are the impacts of the second transition period (2023–2025) on IMP labeling activities? Learn more.